Suvizumab
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1][2]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | HIV-1 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
(what is this?) (verify) |
References
- "Proposed List number 102 of International Nonproprietary Names" (PDF). WHO Drug Information. Geneva: World Health Organization. 23 (4): 344. 2009. ISSN 1010-9609.
- Kerpan I, Walzem F, Kilsen R. Mikrobiologi III: immunsystem (in Swedish). Cambridge Stanford Books.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.